Daily versus alternate day oral iron for iron deficiency anemia

Phase 3

Completed

• Conditions: Health Condition 1: null- Iron deficiency anemia

• Registration Number: CTRI/2018/07/015106
• Lead Sponsor: Department of Internal Medicine PGIMER

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 62

Inclusion Criteria

1. Iron deficiency anemia diagnosed as serum ferritin <15 µg/l

2. Patients of IDA with moderate anemia (8-10.9 g/dl) and severe anemia (6-8 g/dl)

Exclusion Criteria

1.Patients or parents of patients 15-18 years not willing to give informed consent

2.Patients with Hb < 6g/dL

3.Patients of severe anemia in cardiac failure

4.Patients having mild IDA (Hb>=11g/dl)

5.Pregnant females with IDA.

6.Patient with ongoing iron malabsorption or bleed

7.Patient with IDA having mixed etiology for anemia (megaloblastic/ anemia of chronic disease)

Study & Design

• Study Type: Interventional
• Study Design: Not specified